Value of Biosimilars in Women’s Health: HealthyWomen Roundtable Series Roundup

Apr 5, 2021

HealthyWomen, a leader in women’s health education, brought together patient groups, physicians, and industry leaders to discuss how critical biosimilars are to women’s health and how these lower-cost drugs can expand access to life-saving treatments through a series of webinars.

Many autoimmune diseases that affect women in greater numbers than men, such as lupus and rheumatoid arthritis, can be treated with biosimilars, as can breast cancer and many other conditions. Despite these benefits and the fact that women tend to make household health care decisions, a HealthyWomen survey found that 70% of respondents don’t understand originator biologics or biosimilars.

Take a look at our roundup of the series here, and watch the archived conversations here, to learn more about key biosimilars topics, including innovations, overcoming patient access barriers, biosimilars’ impact on our healthcare system, and crucial patient information.